Why do most Tc-99m cold kits contain stannous (Sn²⁺) ion?

Sn²⁺ reduces Tc(VII) pertechnetate to a lower oxidation state so technetium can complex with the ligand. Pertechnetate is Tc(VII) and does not bind most ligands until reduced. Stannous ion provides that reduction. Tin is not the imaging radionuclide, does not replace Mo-99 QC, and does not work by oxidizing pertechnetate to a higher valence for labeling.

A reconstituted kit contains 60 mCi in 3 mL at assay time. What volume is needed for a 20 mCi patient dose if injection is immediate?

1.0 mL. Concentration = 60 mCi / 3 mL = 20 mCi/mL. Volume for 20 mCi = 20/20 = 1.0 mL. 0.33 mL would be only ~6.7 mCi; 3 mL would be the entire vial; 20 mL confuses activity with volume units.

For Tc-99m MAA lung perfusion imaging, which practice is most appropriate?

Reduce the number of particles administered to pediatric patients and patients with pulmonary hypertension per protocol. MAA safety depends on particle number as well as activity. Pediatric patients and those with pulmonary hypertension typically receive fewer particles. Increasing particles in PHTN is unsafe; adult mCi doses are not automatically appropriate for children; a 0.22 μm filter would remove the MAA particles required for lung trapping.

Radiopharmaceutical Kit Preparation — Free Study Guide 2026

A cold kit is a sterile, nonradioactive vial with ligand, usually a reducing agent, and stabilizers. Adding Tc-99m sodium pertechnetate creates the radiopharmaceutical. Domain III expects correct reconstitution, activity/volume limits, patient-dose math, and special rules for MAA.

Cold Kit Reconstitution Workflow

Always follow the package insert:

Verify kit ID, lot, unreconstituted expiration, and storage history.
Assay Tc-99m pertechnetate; confirm Mo-99 and Al³⁺ QC are acceptable.
Aseptically add the correct activity in the correct volume (some kits need diluent or a specific order of addition).
Mix as directed; complete any required incubation or heating (e.g., certain MAG3, sestamibi, or sulfur colloid protocols).
Assay the vial, calculate concentration, and label name, activity, concentration, time, expiration, and lot.
Draw patient doses with a syringe shield, assay each syringe, and document.

Use aseptic technique: sterile needles, swabbed septa, no-touch method, and laminar-flow or equivalent controls when policy/USP <825> practices apply.

Labeling Chemistry (Reduction of Pertechnetate)

Eluate contains pertechnetate, Tc(VII)—chemically unreactive toward most ligands. Kits include stannous ion (Sn²⁺) that reduces technetium so it can complex MDP, DTPA, MIBI, tetrofosmin, mebrofenin, and similar ligands.

Concept	Meaning
TcO₄⁻	Oxidized Tc(VII); “free tech” if unbound
Stannous reduction	Sn²⁺ lowers Tc oxidation state for ligand binding
Air / oxidants	Reoxidation → free pertechnetate
Too much Tc or weak Sn²⁺	Incomplete labeling
HR-Tc	Reduced Tc forming colloid instead of the intended complex

Stay inside insert limits; avoid oxidants and unnecessary air; do not use high-Al³⁺ eluate when warned. Some products use ligand exchange, boiling, or pH control—the core idea remains reduce, then bind.

Activity and Volume Limits

Inserts set max/min Tc-99m activity and reconstitution volume:

Too much activity can overwhelm reducing capacity → poor RCP.
Wrong volume changes concentration and dose logistics.
Insufficient Sn²⁺ relative to Tc → free tech or colloids.

Limits apply at preparation; multi-dose use must stay within post-reconstitution shelf life.

Worked example 1 — Kit limits

Insert: 20–100 mCi in 1–5 mL. Need five ~20 mCi doses → 100 mCi in 5 mL (20 mCi/mL) is within limits. Loading 150 mCi “to save a vial” violates the insert and risks failed QC.

Patient Dose Calculations

\text{Concentration (mCi/mL)} = \frac{\text{Total activity}}{\text{Total volume}}

V = \frac{\text{Ordered activity}}{\text{Concentration}}

Decay if injection is delayed (Tc-99m $T_{1/2} ≈ 6\ \text{h}$ ):

A_t = A_0 \left(\frac{1}{2}\right)^{t/T_{1/2}}

Worked example 2 — Draw volume

80 mCi in 4 mL → 20 mCi/mL. Order 25 mCi → 1.25 mL. Assay the syringe and adjust if needed.

Worked example 3 — Decay

Syringe 25 mCi at 08:00; inject at 11:00 (3 h):

A = 25 \times (1/2)^{3/6} = 25 \times \sqrt{1/2} ≈ 25 \times 0.707 ≈ \mathbf{17.7\ mCi}

If 25 mCi is required at injection, draw more at 08:00 or redraw later.

Worked example 4 — Units

Order 740 MBq MDP → 740/37 = 20 mCi for calibrator math; document in the unit your facility requires.

MAA: Particle Size and Number

Tc-99m MAA is particulate; aggregates temporarily lodge in pulmonary arterioles/capillaries.

Parameter	Teaching range	Why
Particle size	Roughly 10–90 μm	Too small → pass lungs; too large → larger-vessel obstruction
Adult particle number	Often ~200,000–700,000/dose (follow insert)	Uniform map without excess blockade
Pediatrics	Reduce particles (and often activity)	Smaller vascular bed
Pulmonary hypertension / R-to-L shunt protocols	Reduce particles	Limit occlusion / systemic particle risk

Do not inject blood into the MAA vial (clumping); gently resuspend before drawing; never use a 0.22 μm filter that strips particles; reject clumped product. High activity in small volume raises particles per mL—count matters as much as mCi.

Worked example 5 — Particles

Vial: 6 × 10⁶ particles in 6 mL, 30 mCi → 1 × 10⁶ particles/mL and 5 mCi/mL. A 4 mCi adult draw (0.8 mL) ≈ 800,000 particles—may exceed lab ceilings; dilute or prepare lower particle density. Child limited to 100,000 particles → 0.1 mL of that suspension (activity only 0.5 mCi unless a low-density prep is used).

Storage and Expiration

State	Controls
Unreconstituted kit	Labeled fridge or room temp; light protection if stated; freeze only if allowed
After reconstitution	Temp per insert; multi-dose aseptic withdrawals
Expiration	Unreconstituted manufacturer dating; post-reconstitution often ~6–12 h (product-specific)
Eluate age	Some kits prefer fresh eluate

Reject expired kits, failed visual/RCP products, and temperature-abused vials per RSO/pharmacy policy.

Multi-Dose Logistics

Plan kit activity so morning and afternoon lists fit inside both the activity limit and the expiration clock. If the last dose would be drawn after dating, prepare a second kit rather than stretching a marginal vial. Always assay the patient syringe, not only the bulk vial, before administration.

Exam hooks: Sn²⁺ reduces TcO₄⁻; honor activity/volume limits; mCi/mL + decay math; MAA particle number (peds/PHTN); storage/expiration differ before vs after reconstitution.

NMTCB Certified Nuclear Medicine Technologist

5.2 Radiopharmaceutical Kit Preparation

Key Takeaways